—Among patients diagnosed with intermediate-stage age-related macular degeneration, a fair number of eyes in a new analysis showed evidence of geographic atrophy (GA), a leading cause of blindness.

The most advanced form of this condition is called geographic atrophy (GA), in which some retinal cells die off. The condition takes its name from the patches of damage on the retina, which can be ...

Apellis Pharma has become the first company to claim FDA approval for a drug to treat geographic atrophy (GA), a sight ... by the loss of photoreceptors and retinal pigment epithelial (RPE ...

The phase 1b trial will enrol patients with geographic atrophy secondary to age-related ... characterised by the loss of photoreceptors and retinal pigment epithelial (RPE) cells in the central ...

to commence human trials for Eyecyte RPE. According to the company’s press statement, the therapy is aimed at combating geographic atrophy arising from dry age-related macular degeneration (AMD).

Serpiginous chorioretinopathy is a rare form of posterior uveitis that causes inflammation and subsequent atrophy of the choroid, RPE and retina. The disease typically starts near the optic nerve ...

Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including Alzheimer disease and dementia with Lewy bodies.